As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Texas Biomed is offering its research labs to an international biotech company looking to develop new technologies against screwworm.

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.

A medicinal chemist at a biotech company decided to take matters into his own hands after a coworker escalated a simple labeling mistake to management. What could have been a minor error turned into a ...

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory ...

Venture funding and steady openings are pushing Peninsula biotech to hire — and some displaced tech workers may land in labs.

AI, robotics and climate‑tech firms grabbed roughly 30% of Boston’s lab leases in 2025 as vacancy climbs and landlords pivot.